HOME
SEARCH
RSS FEED
SUBSCRIBE
Drug Targets for Fungal-Associated Respiratory Disorders
Case ID:
06.059
Web Published:
9/5/2012
Proteins from the fungus Alternaria have importance in the pathogenesis of some chronic respiratory allergies and disorders. This technology identifies fungal proteins that are critical for the onset of these diseases and are potential drug targets.
US Patent 7,662,400
US Patent 7,887,820
US Patent 7,972,611
Patent Information:
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Patent Status
US Utility
*United States
11/580,454
7,662,400
10/13/2006
2/16/2010
Issued
US Divisional
*United States
12/835,592
7,887,820
7/13/2010
2/15/2011
Abandoned
US Divisional
*United States
12/973,100
7,972,611
12/20/2010
7/5/2011
Expired/Unpaid Fees
Category(s):
Drug Screening
Bookmark this page
Download as PDF
For Information, Contact:
Mike Miller
Senior Licensing Manager
Virginia Tech Intellectual Properties, Inc.
(540) 443-9228
mmiller@vtip.org
Inventors:
Christopher Lawrence
Keywords:
Pharmaceuticals & Biotechnology